CRISPR Therapeutics Company
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Investors
Technology:
AgeTech Companies, CAR-T, Stem cell therapy, Stem cells therapy
Industry:
Healthcare, Public
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2013-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
12
Total Funding:
127000000
Estimated Revenue:
$100M to $500M
Last Funding Date:
2020-12-14
Last Funding Type:
Grant
Register and Claim Ownership